Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
Journal
Expert review of vaccines
Date Issued
2022-11-11
Author(s)
Solante, Rontgene
Alvarez-Moreno, Carlos
Burhan, Erlina
Chariyalertsak, Suwat
Chiu, Nan-Chang
Chuenkitmongkol, Sunate
Dung, D V
Hwang, Kao-Pin
Ortiz Ibarra, Javier
Kiertiburanakul, Sasisopin
Kulkarni, Prasad S
Lee, Christopher
Lobo, Rommel Crisenio
Macias, Alejandro
Nghia, Cao Huu
Ong-Lim, Anna Lisa
Rodriguez-Morales, Alfonso J
Richtmann, Rosana
Safadi, Marco Aurélio Palazzi
Satari, Hindra Irawan
Thwaites, Guy
Abstract
COVID-19 vaccines have been highly effective in reducing morbidity and mortality during the pandemic. However, the emergence of the Omicron variant and subvariants as the globally dominant strains have raised doubts about the effectiveness of currently available vaccines and prompted debate about potential future vaccination strategies.
Subjects
AZD1222; COVID-19; CoronaVac; booster; mRNA; omicron; severe; vaccine effectiveness; waning immunity
Type
journal article